A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in children with HIV infection aged 2 to <15 years old
Active, not recruitingCTIS2024-520388-15-00
Fondazione Penta EtsHIV-infected
Start: 2023-06-30Target: 6Updated: 2025-08-12